A new drug to treat patients who have recurring malaria attacks is in the offing, and is reported to be safer than the one currently in use. The Central Drug Research Institute (CDRI) in Lucknow has completed clinical trials of a new chemically synthesised anti-malaria drug that has evoked interest from the World Health Organisation, the CDRI Director, Dr C M Gupta, said.